← Leaderboards
Alan Horsager
Eos Neuroscience, Inc.
$621,403
Attributed
$1,078,514
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $394.4K · FY2009–12$500K$375K$250K$125K$0
'09
'10
'11
'12
Funding mix
By agency
NIH$1,078,514 · 3
By mechanism
R43$1,078,514 · 3
Top collaborators
- William W Hauswirth2 shared
- Kenneth P Greenberg1 shared
- Douglas G Ririe1 shared
Others in their field
Top investigators on “Retinal”
- John M Lachin · George Washington University$134,552,372
- David M Nathan · Massachusetts Institute Of Technology$124,992,303
- Curtis L Meinert · Johns Hopkins University$72,267,482
- Rose A Gubitosi-Klug · Case Western Reserve University$62,968,469
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Krzysztof Palczewski · University Of California-Irvine$48,804,071
Research focus
RetinalUnited StatesNeuronsResponseRetinal DegenerationTherapeutic GeneDependovirusMouse ModelOpticsProteinsLightGene TherapySmall Business Innovation Research GrantTechnologyBehavioralCationsGenesElectric StimulationNeurosciencesNew TechnologyCellsPhysiologicalCollaborationsVector
Grant awards (4)
Optimization of an Optogenetic-Based Vision Therapy for Retinitis Pigmentosa$295,772
R43 · FY2012 · EY · contact PI
Development of an Optical Silencer Based Genetic Therapy for Neuropathic Pain$394,442
R43 · FY2011 · NS · contact PI
Establishing channelrhodopsin as a tool to restore visual function$86,311
R43 · FY2010 · EY · contact PI
Establishing channelrhodopsin as a tool to restore visual function$301,989
R43 · FY2009 · EY · contact PI